Mr. Buck is currently the Vice President of Regulatory Affairs at n-Lorem Foundation. Since joining Ionis in 2004, Mr. Buck has served as the regulatory lead for Spinraza and Tegsedi and has led the successful marketing authorization applications for Tegsedi in the European Union and U.S. He has served as the regulatory lead for over 15 development compounds of which over half were in development for rare diseases.
Mr. Buck received his J.D. from the University of San Diego and his B.A. from the University of California San Diego.